Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2026-04-09 @ 6:29 PM
Study NCT ID:
NCT03365635
Status:
COMPLETED
Last Update Posted:
2021-12-15
First Post:
2017-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
Sponsor:
University of Pennsylvania
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-29
First Submit QC Date:
None
Study First Post Date:
2017-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-18
Results First Submit QC Date:
None
Results First Post Date:
2021-12-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-17
Last Update Post Date:
2021-12-15
Last Update Post Date Type:
ACTUAL